Available Products
AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone. It is studied separately from intact growth hormone and from compounds that stimulate growth-hormone release. Its identity should not be inferred from the broader phrase “HGH fragment,” which can describe different materials.
Mechanism and Research Context
Published preclinical work examined lipid metabolism in obese mice and beta-3 adrenergic-receptor knockout mice. These experiments investigated the contribution of adrenergic pathways to the metabolic responses associated with the peptide. They provide a mechanistic research context, rather than evidence that a retail research vial produces a particular outcome.
Interpreting the Evidence
Research models, compound identity and formulation matter when interpreting this literature. Findings with intact growth hormone are not interchangeable with findings for AOD-9604. The cited animal study does not establish clinical efficacy or an administration protocol for Captide material.
Available Research Formats
Captide offers AOD-9604 in vial format. The Available Products section above links to the current listing, including strengths, stock status and the associated analytical documents. Product availability is separate from the evidence summarized in this profile.
Research Goals
Documentation and Handling
Read the certificate for the exact sample identity, tested amount and lot. A report for one strength or batch should not be assumed to cover another. Follow the documented storage requirements for the supplied material and the procedures approved for your laboratory.
References
Research use only. Captide products are supplied for laboratory investigation, not for human or veterinary use. This profile provides research context and is not an administration guide.